Article Per Year (5 Year)
p-Index From 2019 - 2024
0.61
P-Index
This Author published in this journals
All Journal Jurnal Kesehatan Jurnal Epidemiologi Kesehatan Komunitas Journal of Health Science and Prevention
Ni Putu Sri Indrani Remitha
Universitas Udayana
Health Professions Medicine & Pharmacology Nursing Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
POTENSI LACTOBACILLUS PLANTARUM SEBAGAI INTERVENSI PENATALAKSANAAN KANKER KOLOREKTAL BERBASIS MODIFIKASI MIKROBIOTA USUS Anak Agung Bagus Putra Indrakusuma; I Gede Krisna Arim Sadeva; Putri Ayu Wulandari; I Gede Wikania Wira Wiguna; Ni Putu Sri Indrani Remitha; I Gusti Ayu Stiti Sadvika; I Gede Putu Supadmanaba; Desak Made Wihandani
Jurnal Kesehatan Vol 13 No 2 (2020): JURNAL KESEHATAN
Publisher : Universitas Islam Negeri Alauddin Makassar

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24252/kesehatan.v13i2.17044

Abstract

Colorectal cancer is a cancer of the colon including the colon and rectum with symptoms such as blood in the stool, anemia, and abdominal pain. This is the third most common cancer worldwide and causes 30.017 cases in Indonesia on 2019. Current treatment of colorectal cancer includes the administration of chemotherapy, surgery, and radiotherapy. However, they are considerably expensive and have many side effects. Lactobacillus plantarum (L. plantarum) is known to have an anticancer effect by influencing carcinogenesis in cell proliferation, apoptosis, and stimulates anticancer immunity. This literature review aims to examine the potential of L. plantarum as an intervention in the management of colorectal cancer based on the modification of the gut microbiota. The writing method used is literature study by examining library sources from five research engines, namely Google Scholar, Pubmed, Plos ONE, Nature, and Sciencedirect. After going through the screening, 79 relevant sources were obtained which were then processed and compiled systematically. L. plantarum suppresses proliferation by inhibiting G1 phase in the cell cycle and targetting ErbB2 and ErbB3. In addition, L. plantarum induces cell death (apoptosis) by activating Bcl-2. These bacteria also stimulate Th1 and inhibit Th2 immune responses.ABSTRAKKanker kolorektal merupakan kanker pada usus besar meliputi kolon dan rektum dengan beberapa gejala seperti darah dalam tinja, anemia, dan nyeri perut. Kanker ini menempati peringkat ketiga di dunia dan menyebabkan 30.017 kasus di Indonesia pada tahun 2019. Penanganan kanker kolorektal saat ini meliputi pemberian obat anti-kanker, pembedahan, dan radioterapi. Akan tetapi, penanganan saat ini dinilai mahal dan menimbulkan efek samping. Salah satu mikrobiota usus, yaitu Lactobacillus plantarum (L. plantarum) diketahui memiliki efek antikanker dengan memengaruhi karsinogenesis pada proliferasi sel, apoptosis, dan sebagai imunoterapi. Metode penulisan yang digunakan adalah studi literatur dengan mengkaji sumber kepustakaan dari lima research engine yaitu Google Scholar, Pubmed, Plos ONE, Nature, dan Sciencedirect. Setelah melalui skrining diperoleh 79 sumber relevan yang kemudian diolah dan disusun secara sistematis. L. plantarum menekan proliferasi melalui mekanisme penghentian fase G1 pada siklus sel dengan target reseptor ialah ErbB2 dan ErbB3. Selain itu, L. plantarum mampu menginduksi kematian sel (apoptosis) dengan mediasi Bcl-2. Bakteri ini juga berperan dalam imunoterapi dengan menstimulasi Th1 dan menghambat Th2 pada host immune system. Literature review ini bertujuan untuk mengkaji potensi L. plantarum sebagai intervensi penatalaksanaan kanker kolorektal berbasis modifikasi mikrobiota usus. 
Small Interfering RNA (siRNA) of Mini circle DNA Transfection (McD) is Encapsulated by Gold Nanoparticles from Folate’s Receptors of Gold Conjugation as Curative Therapy for Non-Small’s Cell of Lung Cancer agung wiwiek indrayani; I Gusti Ayu Sitti Sadvika; I Gede Wikania Wira Wiguna; Ni Putu Sri Indrani Remitha; I Gede Krisna Arim Sadeva; Anak Agung Bagus Putra Indrakusuma; Putri Ayu Wulandari; Ni Wayan Sucindra Dewi
Jurnal Epidemiologi Kesehatan Komunitas Vol 6, No 2: Agustus 2021
Publisher : Master of Epidemiology, School of Postgraduate Studies, Diponegoro University, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.14710/jekk.v6i2.9140

Abstract

Background: Lung cancer is one of the non-communicable diseases that have an increasing number of events that each year with a mortality rate of 18.4% and an incidence of 11.6%, occupies the top position based on GLOBOCAN data in 2018. One of management in the NSCLC is currently in the form of surgery and adjuvant therapy such as chemotherapy, radiotherapy and target therapy. However, there were weaknesses and limitations in care for its patients therefore development of curative therapy for NSCLC’s patients were needed.  The aim of this review is to learn and investigate about the potential of siRNA that is transfected into McD and folate receptors alpha-conjugated gold nanoparticle encapsulation as a therapeutic opportunity that could be developed as a treatment in management of NSCLC.Method: The writing method used in this review article was the study method of literature.  The used data comes from 45 of relevant literature sources and was arranged systematically in accordance with the topic of the problem discussed, along with the inclusion and exclusion criteria.Result: This treatment could increase gene transfection, siRNA biodistribution in organs, reduced KRAS, Bcl-2, and VEGF expression.  Moreover, siRNA had entered phase III clinical trials and FOLR1 antibodies were in phase II of clinical trials.Conclusion: Utilization of siRNA specifically was designed for three genes such for KRAS, VEGF and Bcl-2 which were three genes that played a role in the pathogenesis of NSCLC, could be the right modality choice for treatment of NSCLC. 
SiRNA Berbasis Aptamer-PLEGP1800 Enkapsulasi Chitosan : Literature Review Penatalaksanaan Triple Negative Breast Cancer Ni Putu Sri Indrani Remitha; Andreliano Yosua Rompis; Made Violin Weda Yani; I Gede Wikania Wira Wiguna; I Gusti Ayu Stiti Sadvika; I Gusti Made Anom Darma Putra
Journal of Health Science and Prevention Vol. 4 No. 2 (2020): JHSP Vol 4 No 2 - 2020
Publisher : State Islamic University of Sunan Ampel

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29080/jhsp.v4i2.369

Abstract

Triple Negative Breast Cancer (TNBC) memiliki karakteristik yang berbeda dengan jenis kanker payudara pada umumnya karena bersifat agresif, resisten terhadap pengobatan, proliferasi yang tinggi, dan angka harapan hidup yang rendah. Pemanfaatan siRNA spesifik silencing gen mutan p53 dan VEGF sebagai penatalaksanaan TNBC merupakan metode yang menjanjikan. Penulisan literature review ini bertujuan untuk mengkaji mekanisme dan efek klinis siRNA-Aptamer-PLEGP1800-Chitosan sebagai terapi TNBC berbasis teknologi nano. Metode yang digunakan dalam penulisan literature review ini adalah kajian pustaka dengan data menggunakan search engine seperti NCBI, Pubmed, dan Google Scholar sehingga ditemukan 28 jurnal yang sesuai dengan kriteria inklusi dan eksklusi. SiRNA akan dikonjugasi dengan aptamer dan PLEGP1800. SiRNA-Aptamer-PLEGP1800 juga akan dienkapsulasi dengan chitosan untuk meningkatkan bioavailabilitas dan melindungi senyawa di dalamnya dari degradasi serum. Efek klinis beberapa penelitian menunjukkan bahwa Silencing mut-p53 dan TNF secara bersamaan menyebabkan hilangnya viabilitas sel, serta Pemberian siRNA/PLEGP1800 nanocomplex menurunkan ekspresi gen VEGF. Hal tersebut menunjukkan bahwa siRNA-Aptamer-PLEGP1800-Chitosan memiliki prospek yang baik sebagai penatalaksanaan TNBC.
Co-Authors Agung Wiwiek Indrayani Anak Agung Bagus Putra Indrakusuma Andreliano Yosua Rompis Desak Made Wihandani I G. P. Supadmanaba I Gede Krisna Arim Sadeva I Gede Wikania Wira Wiguna I Gusti Ayu Sitti Sadvika I Gusti Ayu Stiti Sadvika I Gusti Made Anom Darma Putra Made Violin Weda Yani Ni Wayan Sucindra Dewi Putri Ayu Wulandari